Clinical Impact of New Data From the IAS 2020 Virtual COVID-19 Conference

Virtual
In this downloadable slideset, CCO’s expert faculty summarizes key studies from this important conference, including new data on predictors of COVID-19 mortality, emerging COVID-19 treatment strategies, and the effect of race/ethnicity on COVID-19 treatment outcomes.
Format: Microsoft PowerPoint (.ppt)
File Size: 487 KB
Released: July 24, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.

Related Content

Clinical Care Options’ (CCO) commentary from Dr. Sharon Lewin on new data on monoclonal antibodies for COVID-19 prevention and treatment

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: July 7, 2021

Clinical Care Options’ (CCO) commentary from Dr. Gregory Olson and colleagues on COVID-19 vaccination in immunocompromised patients

person default Christopher J. Lehmann, MD person default Gregory Olson, MD Renslow Sherer, MD Released: June 28, 2021

Clinical Care Options’ (CCO) expert commentary from Dr. Renslow Sherer and colleagues on the risk of severe COVID-19 in patients with HIV and/or other forms of immunocompromise

person default Christopher J. Lehmann, MD person default Gregory Olson, MD Renslow Sherer, MD Released: June 10, 2021

Clinical Care Options’ (CCO) commentary from a person with HIV on what it was like living through the COVID-19 pandemic as a long-term HIV survivor

person default Frank Primavera Released: June 9, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue